Here, to validate this finding, we use lentiviral gRNAs against SRPK1 to markedly reduce SRPK1 protein levels in Cas9-expressing AML cell lines and primary murine AMLs (Supplementary Fig. 1a–f). Here, SRPK1 is linked to acute myeloid leukemia.